PLX
- Product code
- PLX
- Device name
- Tear Duct Occluder
- Device class
- Class 1
- 21 CFR
- 21 CFR 886.5838
- Medical specialty
- Ophthalmic
- Marketing pathway
- 510(K) Exempt
- 510(k) clearances (all years, FDA)
- 1 (all years; only the last 3 years are listed here)
FDA classification definition
A nasolacrimal compression device is a device used to compress the nasolacrimal ducts to reduce drainage by means of temporary occlusion of the nasolacrimal system. The device may include a nose piece attached to a frame to apply pressure to the duct.
Official FDA classification page: PLX
Classification and pathway per current FDA publications. Data from openFDA (CC0).